Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.
Thi Huyen Tram NguyenJeremie GuedjXavier AnglaretCédric LaouénanVincent MadelainAnne-Marie TaburetSylvain BaizeDaouda SissokoBoris PastorinoAnne RodallecGéraldine PiorkowskiSara Carazo PerezMamoudou N CondeJean-Luc GalaJoseph Akoi BoreCaroline CarbonnelleFrédéric JacquotHervé RaoulDenis MalvyXavier Nicolas de LamballerieFrance Mentrénull nullPublished in: PLoS neglected tropical diseases (2017)
ClinicalTrials.gov NCT02329054.